Back to search

Ireland· IE-PA-PA1986/085/002

Nortem 20mg Tablets

A temazepam product containing temazepam, registered in Ireland by Teva B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC N05CD07

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedNortem 20mg TabletsATCN05CD07REGISTER NO.IE-PA-PA1986/085/002PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Temazepam is registered in 9 of 19 countries.

Countries holding a registration under ATC N05CD07 (temazepam), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 4 of them publish a price we can compare per daily dose

Temazepam · ATC N05CD07

9 / 19 countries

  • Canada
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of temazepam costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Temazepam · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.79
  • US United States$0.74 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Temazepam
Manufacturer
Teva B.V.
Country
Ireland (IE)
ATC code
N05CD07
ATC class
Temazepam
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1986/085/002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

319 interactions on record for temazepam.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Temazepam · interactions on record

319 records

  • 4 severe
  • 72 moderate
  • 22 minor
  • 218 info

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Temazepam in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All temazepam products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Germany · Remestan, Remestan Mite
  • Finland · Tenox
  • United Kingdom (Northern Ireland) · Temazepam, Temazepam Generics [uk]
  • Hungary · Signopam
  • Malta · Temazepam Thame
  • Netherlands · Temazepam Auro, Temazepam Aurobindo
  • Poland · Signopam, Teseda
  • Portugal · Normison

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e8d0acb2-8a87-4042-b347-6fbf0acf60bb
GET /v1/drugs/e8d0acb2-8a87-4042-b347-6fbf0acf60bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "N05CD",
    "N05CD07"
  ],
  "strength": null,
  "pa_number": "PA1986/085/002",
  "substances": [
    "Temazepam"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "13/12/1993",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about temazepam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.